Ref Rencs Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. 2003. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 131(1):757–770. Abou M, Eltahir Y, Ali A. 2009. Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan. Virol J 6:146; doi:10.1186/1743-422X- 6-146 [Online 23 September 2009]. Alam M, Zaidi S, Malik S, Naeem A, Shaukat S, Sharif S, et al. 2007. Serology based disease status of Pakistani popula- tion infected with Hepatitis B virus. BMC Infect Dis 7:64; doi:10.1186/1471-2334-7-64 [Online 27 June 2007]. Ali N, Hashim NH, Yoshizawa T. 1999. Evaluation and appli- cation of a simple and rapid method for the analysis of aflatoxins in commercial foods from Malaysia and the Philippines. Food Addit Contam Part A 16(7):273–280. Ali N, Sardjono, Yamashita A, Yoshizawa T. 1998. Natural co-occurrence of aflatoxins and Fusavium mycotoxins (fumo- nisins, deoxynivalenol, nivalenol and zearalenone) in corn from Indonesia. Food Addit Contam Part A 15(4):377–384. Ali SA, Donahue RMJ, Qureshi H, Vermund SH. 2009. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 13(1):9–19. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. 2005. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 45(12):1973–1980. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA. 2008. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 659(1–2):176–184. Ayalew A, Fehrmann H, Lepschy J, Beck R, Abate D. 2006. Natural occurrence of mycotoxins in staple cereals from Ethiopia. Mycopathologia 162(1):57–63. Bandyopadhyay R, Kumar M, Leslie JF. 2007. Relative severity of aflatoxin contamination of cereal crops in West Africa. Food Addit Contam: Part A 24(10):1109–1114. Bankole SA, Mabekoje OO. 2004. Occurrence of aflatoxins and fumonisins in preharvest maize from south-western Nigeria. Food Addit Contam: Part A 21(3):251–255. Batayneh N, Bdour S. 2002. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol 10(3):127–132. Batina A, Kabemba S, Malengela R. 2007. Infectious markers among blood donors in Democratic Republic of Congo (DRC). Rev Med Brux 28(3):145–149. Battilani P, Barbano C, Piva G. 2008. Aflatoxin B1 contamination in maize related to the aridity index in North Italy. World Mycotox J 1(4):449–456. Behal R, Jain R, Behal KK, Bhagoliwal A, Aggarwal N, Dhole TN. 2008. Seroprevalence and risk factors for hepatitis B virus infection among general population in Northern India. Arq Gastroenterol 45(2):137–140. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. 2003. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 21(7–8):685–691. Butt T, Amin M. 2008. Seroprevalence of hepatitis B and C infections among young adult males in Pakistan. East Mediterr Health J 14(4):791–797. Centers for Disease Control and Prevention. 2009. Disease Burden from Viral Hepatitis A, B, and C in the United States. Available: http://www.cdc.gov/hepatitis/Statistics. htm#section1 [accessed 5 November 2009]. Central Intelligence Agency. 2009. World Factbook. Available: https://www.cia.gov/library/publications/the- world-factbook/index.html [accessed 18 August 2009]. Chen H, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. 1996. Seroepidemiology of hepatitis B virus infection in chil- dren: ten years of mass vaccination in Taiwan. JAMA 276(11):906–908. Cohen C, Evans AA, London WT, Block J, Conti M, Block T. 2008. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat 15(1):12–13. Cunha L, Plouzeau C, Ingrand P, Gudo JPS, Ingrand I, Mondlane J, et al. 2007. Use of replacement blood donors to study the epi- demiology of major blood-borne viruses in the general popu- lation of Maputo, Mozambique. J Med Virol 79(12):1832–1840. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. 2004. Global epidemiology of hepatitis B virus. J Clin Gastroentorol 38(10 suppl 3):S158–S168. Da Villa G, Piccinino, Scolastico C, Fusco M, Piccinino R, Sepe A. 1998. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, south- ern Italy): results of a pilot vaccination project. Res Virol 149(5):263–270. Domingo E. 1997. Chronic hepatitis B in the Philippines: problems posed by the hepatitis B surface antigen-positive carrier. In: Hepatitis B in the Asian-Pacific Region, vol. 1— Screening, Diagnosis and Control (Zuckerman A, ed). London:Royal College of Physicians, 103–113. Elsheikh R, Daak A, Elsheikh M, Karsany M, Adam I. 2007. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J 4:104; doi:10.1186/1743-422X-4-104 [Online 24 October 2007]. Etcheverry M, Nesci A, Barros G, Torres A, Chulze S. 1999. Occurrence of Aspergillus section Flavi and afla- toxin B1 in corn genotypes and corn meal in Argentina. Mycopathologia 147(1):37–41. Fasola F, Kotila T, Akinyemi J. 2008. Trends in transfusion- transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria. Intervirology 51(6):427–431. Ferlay J, Bray F, Pisani P, Parkin DM. 2004. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Available: http:// www-dep.iarc.fr. Available: http://www-dep.iarc.fr/globo- can/downloads.htm [accessed 27 April 2010]. García S, Heredia N. 2006. Mycotoxins in Mexico: epidemiol- ogy, management, and control strategies. Mycopathologia 162(3):255–264. Giray B, Girgin G, Engin AB, AydIn S, Sahin G. 2007. Aflatoxin lev- els in wheat samples consumed in some regions of Turkey. Food Control 18(1):23–29; doi:10.1016/j.foodcont.2005.08.002 [Online 29 September 2005]. Gnonlonfin GJ, Hell K, Fandohan P, Siame AB. 2008. Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa. Int J Food Microbiol 122(1–2):140–147. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. 2003. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 18(6):551–557. Groopman JD, Johnson D, Kensler TW. 2005. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex envi- ronmental exposures and cancer risk. Cancer Biomark 1(1):5–14. Groopman JD, Kensler TW, Wild CP. 2008. Protective inter- ventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu Rev Public Health 29:187–203. Gust ID. 1996. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38(suppl 2):S18–S23. Guzmán-de-Peña D, Peña-Cabriales JJ. 2005. Regulatory con- siderations of aflatoxin contamination of food in Mexico. Rev Latinoam Microbiol 47(3–4):160–164. Hadiani M, Yazdanpanah H, Amirahmadi M, Soleimani H, Shoeibi S, Khosrokhavar R. 2009. Evaluation of aflatoxin contamination in maize from Mazandaran province in Iran. J Med Plants 8(suppl 5):109–114. Hahné S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. 2004. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. J Clin Virol 29(4):211–220. Hall AJ, Wild CP. 1994. Epidemiology of aflatoxin-related disease. In: The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance (Eaton DA, Groopman JD, eds). San Diego, CA:Academia Press, 233–258. Hasegawa I, Tanaka Y, Kurbanov F, Yoshihara N, El-Gohary A, Lyamuya E, et al. 2006. Molecular epidemiology of hepati- tis B virus in the United Republic of Tanzania. J Med Virol 78(8):1035–1042. Henry SH, Bosch FX, Troxell TC, Bolger PM. 1999. Policy forum: public health. Reducing liver cancer—global control of aflatoxin. Science 286(5449):2453–2454. Hong Z, Zou S, Giulivi A. 2001. Hepatitis B and its control in Southeast Asia and China. Can Commun Dis Rep 27(suppl 3):31–33. Available: http://www.phac-aspc.gc.ca/publicat/ ccdr-rmtc/01vol27/27s3/27s3k_e.html [accessed 19 May 2010]. IARC (International Agency for Research on Cancer). 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum 82:171–300. International Programme on Chemical Safety and WHO. 1998. Environmental Health Perspectives • volume 118 | number 6 | June 2010 Global burden of aflatoxin-induced liver cancer International Programme on Chemical Safety. Safety eval- uation of certain food additives and contaminants. WHO Food Additives Series 40. Available: http://www.inchem. org/documents/jecfa/jecmono/v040je01.htm [accessed 19 May 2010]. Ismail AM, Ziada HN, Sheashaa HA, Shehab El-Din AB. 2009. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope. Eur J Int Med 20(5):490–493. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T, et al. 2006. Hepatitis B and C: prevalence and risk factors asso- ciated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 6:101; doi:10.1186/1471-2334-6- 101 [online 23 June 2006]. Jilg W, Hottenträger B, Weinberger K, Schlottmann K, Frick E, Holstege A, et al. 2001. Prevalence of markers of hepatitis B in the adult German population. J Med Virol 63(2):96–102. Jutavijittum P, Jiviriyawat Y, Yousukh A, Hayashi S, Toriyama K. 2005. Evaluation of a hepatitis B vaccination program in Chiang Mai, Thailand. Southeast Asian J Trop Med Public Health 36(1):207–212. Kafi-Abad SA, Rezvan H, Abolghasemi H. 2009a. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998–2007. Transfus Med 19(4):189–194. Kafi-Abad SA, Rezvan H, Abolghasemi H, Talebian A. 2009b. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49(10):2214–2220. Khattak M, Salamat N, Bhatti FA, Qureshi TZ. 2002. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 52(9):398–402. Kiire CF. 1996. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and sub- tropical Africa. Gut 38(suppl 2):S5–S12. Kirk GD, Bah E, Montesano R. 2006. Molecular epidemiol- ogy of human liver cancer: insights into etiology, patho- genesis and prevention from The Gambia, West Africa. Carcinogenesis 27(10):2070–2082. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, et al. 2004. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39(1):211–219. Kirk GD, Lesi OA, Mendy M, Szymanska K, Whittle H, Goedert JJ, et al. 2005. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carci- noma. Oncogene 24(38):5858–5867. Kuang S-Y, Lekawanvijit S, Maneekarn N, Thongsawat S, Brodovicz K, Nelson K, et al. 2005. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 muta- tions in hepatocellular carcinomas from Thailand. Cancer Epidemiol Biomarkers Prev 14(2):380–384. Kuiper-Goodman T. 1995. Mycotoxins: risk assessment and legislation. Toxicol Lett 82–83:853–859. Lansang M. 1996. Epidemiology and control of hepatitis B infec- tion: perspective from the Philippines, Asia. Gut 38(suppl 2):S43–S47. Lehman EM, Wilson ML. 2009. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy peo- ple in Egypt: a systematic review and meta-analysis. Int J Cancer 124(3):690–697. Li FQ, Yoshizawa T, Kawamura O, Luo XY, Li YW. 2001. Aflatoxins and fumonisins in corn from the high-incidence area for human hepatocellular carcinoma in Guangxi, China. J Agric Food Chem 49(8):4122–4126. Lipigorngoson S, Limtrakul P, Suttajit M, Yoshizawa T. 2003. In-house direct cELISA for determining aflatoxin B 1 in Thai corn and peanuts. Food Addit Contam Part A 20(9):838–845. Magdzik W. 2000. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 18(suppl 1):S13–S16. Malir F, Ostry V, Grosse Y, Roubal T, Skarkova J, Ruprich J. 2006. Monitoring the mycotoxins in food and their biomarkers in the Czech Republic. Mol Nutr Food Res 50(6):513–518. Manjula K, Hell K, Fandohan P, Abass A, Bandyopadhyay R. 2009. Aflatoxin and fumonisin contamination of cas- sava products and maize grain from markets in Tanzania and republic of the Congo. Toxin Rev 28:63; doi:10.1080/15569540802462214 [Online 2 May 2009]. Matee M, Magesa P, Lyamuya E. 2006. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. 823